Reimbursement practices (% where it is standard, percentage of projects that reimburse, and typical amounts provided) by organisation type, main target group, and main research method
Reimbursement is standard* (n = 97)† | Percentage of projects that reimburse (n = 64)‡ | Typical reimbursement amounts provided ($AUD) | ||||
---|---|---|---|---|---|---|
n | % | Median | Range | Median | Range | |
*Standard refers to occurring in the majority of projects. | ||||||
†Data missing for three respondents. | ||||||
‡Where reimbursement is provided at all. | ||||||
§Data missing for four respondents. | ||||||
¶Data missing for three respondents. | ||||||
**Data missing for one respondent. | ||||||
ATSI, Aboriginal and Torres Strait Islander; AUD, Australian dollars. | ||||||
Organisation type§ | ||||||
Research centre/institute (n = 25) | 11 | 44 | 50 | 1–100 | 22.50 | 5–100 |
Hospital (n = 21) | 6 | 29 | 50 | 1–100 | 20.00 | 6–100 |
Government (n = 9) | 4 | 44 | 100 | 60–100 | 25.00 | 20–75 |
University (n = 37) | 12 | 32 | 73 | 5–100 | 20.00 | 15–110 |
Market research (n = 3) | – | – | 33 | 1–65 | 60.00 | – |
Pharmaceutical company (n = 1) | – | – | 25 | – | 200.00 | – |
Target group¶ | ||||||
Drug dependent (n = 19) | 12 | 63 | 78 | 20–100 | 20.00 | 15–100 |
Children/youth (n = 11) | 4 | 36 | 45 | 1–75 | 15.00 | 10–20 |
Health professionals (n = 6) | 1 | 17 | 50 | 30–100 | 110.00 | – |
ATSI (n = 5) | 2 | 40 | 60 | 5–100 | 15.00 | 5–25 |
Patients (n = 20) | 4 | 20 | 23 | 1–100 | 100.00 | 6–200 |
General population (n = 11) | 4 | 36 | 75 | 1–100 | 25.00 | 20–60 |
Mix (n = 25) | 6 | 24 | 25 | 5–100 | 25.00 | 15–110 |
Method** | ||||||
Mixed (qualitative and quantitative) (n = 37) | 11 | 30 | 50 | 1–100 | 20.00 | 6–75 |
Epidemiology (n = 17) | 6 | 35 | 78 | 10–100 | 20.00 | 15–30 |
Evaluation (n = 7) | 2 | 33 | 7 | 2–100 | 110.00 | 5–110 |
Clinical research (n = 32) | 11 | 34 | 55 | 1–100 | 40.00 | 20–200 |
Market research (n = 4) | 2 | 50 | 63 | 1–90 | 25.00 | 25–60 |
Social research (n = 2) | 1 | 50 | 60 | 1–100 | 20.00 | 20–25 |